Search

Your search keyword '"Macro, M."' showing total 14 results
Start Over Author "Macro, M." Publisher wiley
14 results on '"Macro, M."'

1. Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.

Author

Carras, S., primary, Torroja, A., additional, Emadali, A., additional, Daguindau, N., additional, Tempescul, A., additional, Macro, M., additional, Moreau, A., additional, Tchernonog, E., additional, Houot, R., additional, Schmitt, A., additional, Dartigeas, C., additional, Dupuis, J., additional, Jardin, F., additional, Banos, A., additional, Corm, S., additional, Barbieux, S., additional, Zerazhi, H., additional, Arkam, Y., additional, Fouillet, L., additional, Fontan, J., additional, Vilque, J., additional, Moles, M., additional, Sarkozy, C., additional, Morineau, N., additional, Joly, B., additional, Voillat, L., additional, Alexis, M., additional, Fornecker, L. M., additional, Garidi, R., additional, Amorim, S., additional, Bouabdallah, K., additional, Dorvaux, V., additional, Chabrot, C., additional, Feugier, P., additional, Damaj, G., additional, Fleury, J., additional, Delwail, V., additional, Ysebaert, L., additional, Burroni, B., additional, Callanan, M., additional, Legouill, S., additional, and Gressin, R., additional

Published
2023
Full Text
View/download PDF

2. P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED ANALYSIS OF THE PHASE 3 MAIA STUDY

Author

Weisel, K., primary, Kumar, S., additional, Moreau, P., additional, Bahlis, N., additional, Facon, T., additional, Plesner, T., additional, Orlowski, R., additional, Basu, S., additional, Nahi, H., additional, Hulin, C., additional, Quach, H., additional, Goldschmidt, H., additional, O’Dwyer, M., additional, Perrot, A., additional, Venner, C., additional, Raje, N., additional, Tiab1, M., additional, Macro, M., additional, Frenzel, L., additional, Leleu, X., additional, Pei, H., additional, Krevvata, M, additional, Carson, R, additional, Borgsten, F., additional, and Usmani, S., additional

Published
2023
Full Text
View/download PDF

3. P872: DEL(1P32) REMAINS A POWERFUL PROGNOSTIC FACTOR IN A LARGE COHORT OF NDMM PATIENTS: AN UPDATE

Author

Schavgoulidze, A., primary, Perrot, A., additional, Cazaubiel, T., additional, Leleu, X., additional, Manier, S., additional, Buisson, L., additional, Maheo, S., additional, Do Souto Ferreira, L., additional, Lannes, R., additional, Pavageau, L., additional, Hulin, C., additional, Marolleau, J.-P., additional, Voillat, L., additional, Belhadj, K., additional, Divoux, M., additional, Slama, B., additional, Brechignac, S., additional, Macro, M., additional, Stoppa, A.-M., additional, Sanhes, L., additional, Orsini-Piocelle, F., additional, Fontan, J., additional, Chretien, M.-L., additional, Demarquette, H., additional, Mohty, M., additional, Avet-Loiseau, H., additional, and Corre, J., additional

Published
2022
Full Text
View/download PDF

4. P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

Author

Lee, H. C., primary, Ramasamy, K., additional, Macro, M., additional, Davies, F. E., additional, Abonour, R., additional, van Rhee, F., additional, Hungria, V. T., additional, Puig, N., additional, Ren, K., additional, Silar, J., additional, Enwemadu, V., additional, Cherepanov, D., additional, Stull, D. M., additional, and Leleu, X., additional

Published
2022
Full Text
View/download PDF

5. HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R-CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

Author

Cottereau, A., primary, Vercellino, L., additional, Casasnovas, O., additional, Tilly, H., additional, Feugier, P., additional, Fruchart, C., additional, Roulin, L., additional, Oberic, L., additional, Pica, G., additional, Ribrag, V., additional, Abraham, J., additional, Simon, M., additional, Gonzalez, H., additional, Bouabdallah, R., additional, Fitoussi, O., additional, Sebban, C., additional, Lopez, A., additional, Macro, M., additional, Sahnes, L., additional, Morschhauser, F., additional, Trotman, J., additional, Corront, B., additional, Choufi, B., additional, Snauwaert, S., additional, Godmer, P., additional, Copie-Bergman, C., additional, Briere, J., additional, Salles, G., additional, Gaulard, P., additional, Meignan, M., additional, and Thieblemont, C., additional

Published
2019
Full Text
View/download PDF

6. FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL

Author

Gressin, R., primary, Daguindau, N., additional, Tempescul, A., additional, Moreau, A., additional, Carras, S., additional, Cartron, G., additional, Schmitt, A., additional, Houot, R., additional, Dartigeas, C., additional, Pignon, J., additional, Corm, S., additional, Bannos, A., additional, Mounier, C., additional, Dupuis, J., additional, Macro, M., additional, Fleury, J., additional, Jardin, F., additional, Karlin, L., additional, Damaj, G., additional, Feugier, P., additional, Fornecker, L., additional, Chabrot, C., additional, Ysebaert, I., additional, Callanan, M., additional, and Le Gouill, S., additional

Published
2017
Full Text
View/download PDF

7. Modulation of rabbit articular chondrocyte (RAC) proliferation by TGF-β isoforms

Author

Karim Boumediene, Patrick Bogdanowicz, Denis Vivien, Pujol Jp, Macro M, and Lebrun E

Subjects
Cartilage, Articular, Gene isoform, medicine.diagnostic_test, Cell Cycle, DNA replication, Cell Count, Endogeny, Cell Biology, General Medicine, Cell cycle, Biology, Flow Cytometry, Tritium, Molecular biology, Flow cytometry, Paracrine signalling, Transforming Growth Factor beta, medicine, Animals, Rabbits, Beta (finance), Autocrine signalling, Cell Division, Cells, Cultured, Thymidine
Abstract

We have previously shown that TGF-beta 1 exerts a bifunctional effect on RAC proliferation. Added to quiescent cultures, it inhibits the entry of G0/G1 cells into S phase whereas in S phase synchronized populations, it stimulates the DNA replication rate with a delayed G2 + M phase and a subsequent transient increase of cell number. As TGF-beta 2 and beta 3 isoforms are also expressed in bone and cartilage tissues, it was of interest to study their effect on RAC proliferation, in comparison to that of TGF-beta 1. Using cell counting and tritiated thymidine incorporation, we found that all the TGF-beta s used here induced an increase of RAC proliferation rate occurring between 24 and 48 h of exposure. TGF-beta 2 appeared as the most efficient form as judged from the maximum of thymidine labelling. However, TGF-beta 3 induced an increase of cell number slightly higher than both TGF-beta 1 and TGF-beta 2 (+30% versus 20% for TGF-beta 1 and beta 2). TGF-beta 2 and beta 3 were able to stimulate the DNA replication rate as previously demonstrated for TGF-beta 1. However, the effect occurred later for TGF-beta 2 and beta 3 (12 h) than for TGF-beta 1 (6 h). This was confirmed by flow cytometric analysis of DNA content. In addition, immunodetection by flow cytometry demonstrated that all TGF-beta isoforms enhanced endogenous expression of TGF-beta-related peptides. The effect was shown to be associated with the cell cycle S phase and was greater for TGF-beta 3 than for TGF-beta 1 and beta 2. These findings suggest that TGF-beta s could act on RAC functions via autocrine and paracrine ways. Taken together, these data indicate that TGF-beta s may modulate proliferation of articular chondrocytes and therefore could play a role in the activation of these cells in the early stages of osteoarthritis.

Published
1995
Full Text
View/download PDF

13. [Untitled]

Author

Giuliano Mengoli, Macro M. Musiani, Carlo Folonari, and Beatrice Pelli

Subjects
In situ, Electrolysis, Materials science, Inorganic chemistry, law.invention, Anode, chemistry.chemical_compound, chemistry, Polymerization, law, Pyridine, Oxidative coupling of methane, Methanol, Derivative (chemistry)
Abstract

Three different azophenols were oxidized by both the system CuCl/O2 in pyridine and electrochemically (as coherent films) on Fe and Cu anodes in water/methanol mixtures. Products of the chemical and anodic oxidative coupling process are in any case very near each other. Poly(oxy-4-phenylazo-1,2-phenylene) and its 3-allyl derivative are obtained from 4-hydroxyazobenzene (1) and 3-allyl-4-hydroxyazobenzene (2), respectively. The polymerization of 4-hydroxy-3,5-dimethylazobenzene (3) mainly proceeds through elimination of the phenylazo group and formation of poly(oxy-2,6-dimethyl-1,4-phenylene). By oxidation of 2 at Cu anodes thin, adherent films having very good protective features are obtained in short electrolysis times.

Published
1982
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results